Eli Lilly, Centessa filed HSR Act premerger forms on April 21
( May 7, 2026, 13:22 GMT | Official Statement) -- MLex Summary: Eli Lilly and Centessa Pharmaceuticals filed their Hart-Scott-Rodino Act premerger forms with the Federal Trade Commission and Department of Justice on April 21, according to a US securities filing. The 30-day waiting period is set to expire on May 21, barring a pull and refile, second request from either agency, or an early termination.See excerpt below....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.